David M. Wolfsohn, MD, is an assistant clinical professor at Yale School of Medicine. He serves as the director of Innovation and an International Medicine leader for the Division of Digestive Diseases. He has a strong interest in luminal disorders, Barrett’s esophagus, colon cancer, and preventative health as it relates to the gastrointestinal (GI) tract.
Dr. Wolfsohn joined the Yale faculty after spending 27 years caring for patients in private practice with Connecticut Gastroenterology Consultants, where he served on the executive committee of the group for more than 20 years.
Dr. Wolfsohn serves on the science advisory board and board of directors of pHlip, Inc., a biotechnology company that studies novel therapies to diagnose and treat inflammatory and neoplastic conditions, which has provided him with exciting opportunities for research. He is additionally involved in conducting research with a group of Yale neurologists on the role of the gut microbiome and neuroinflammatory conditions.
Dr. Wolfsohn graduated from Brown University magna cum laude and as a member of the Sigma Xi honor society. He received his medical degree from Cornell University Medical College and completed his residency in internal medicine at Cornell-New York Hospital. He completed his fellowship in gastroenterology at the University of California, San Diego, which included training in advanced procedures.
His interests include skiing, mountaineering, hiking, kayaking, playing the guitar, and traveling with his family.